nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—NME1—breast cancer	0.461	1	CbGaD
Adefovir Dipivoxil—SLC22A3—Melphalan—breast cancer	0.109	0.408	CbGbCtD
Adefovir Dipivoxil—ABCC5—Fluorouracil—breast cancer	0.06	0.224	CbGbCtD
Adefovir Dipivoxil—SLC22A3—Irinotecan—breast cancer	0.037	0.138	CbGbCtD
Adefovir Dipivoxil—ABCC4—Fluorouracil—breast cancer	0.0288	0.108	CbGbCtD
Adefovir Dipivoxil—ABCC4—Methotrexate—breast cancer	0.0159	0.0594	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Methotrexate—breast cancer	0.00993	0.0371	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Methotrexate—breast cancer	0.00692	0.0258	CbGbCtD
Adefovir Dipivoxil—AK2—mammary gland—breast cancer	0.00304	0.057	CbGeAlD
Adefovir Dipivoxil—Tenofovir—NME1—breast cancer	0.00283	1	CrCbGaD
Adefovir Dipivoxil—AK4—mammary gland—breast cancer	0.00225	0.0421	CbGeAlD
Adefovir Dipivoxil—AK4—nipple—breast cancer	0.00186	0.0349	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—female reproductive system—breast cancer	0.00166	0.0311	CbGeAlD
Adefovir Dipivoxil—NME2—embryo—breast cancer	0.0015	0.0281	CbGeAlD
Adefovir Dipivoxil—NME1—Gefitinib—Lapatinib—breast cancer	0.00146	0.649	CbGdCrCtD
Adefovir Dipivoxil—NME1-NME2—endocrine gland—breast cancer	0.00141	0.0263	CbGeAlD
Adefovir Dipivoxil—AK2—uterus—breast cancer	0.0014	0.0262	CbGeAlD
Adefovir Dipivoxil—AK2—adipose tissue—breast cancer	0.00137	0.0256	CbGeAlD
Adefovir Dipivoxil—ABCC5—mammary gland—breast cancer	0.00128	0.0239	CbGeAlD
Adefovir Dipivoxil—NME1—skin of body—breast cancer	0.00124	0.0232	CbGeAlD
Adefovir Dipivoxil—AK2—adrenal gland—breast cancer	0.00123	0.023	CbGeAlD
Adefovir Dipivoxil—NME2—epithelium—breast cancer	0.00123	0.0229	CbGeAlD
Adefovir Dipivoxil—AK2—bone marrow—breast cancer	0.00119	0.0223	CbGeAlD
Adefovir Dipivoxil—AK2—female gonad—breast cancer	0.00115	0.0214	CbGeAlD
Adefovir Dipivoxil—AK4—endometrium—breast cancer	0.00112	0.021	CbGeAlD
Adefovir Dipivoxil—NME1—uterus—breast cancer	0.00108	0.0201	CbGeAlD
Adefovir Dipivoxil—NME1—adipose tissue—breast cancer	0.00105	0.0197	CbGeAlD
Adefovir Dipivoxil—AK4—uterus—breast cancer	0.00104	0.0194	CbGeAlD
Adefovir Dipivoxil—AK4—pituitary gland—breast cancer	0.00102	0.019	CbGeAlD
Adefovir Dipivoxil—AK4—adipose tissue—breast cancer	0.00101	0.019	CbGeAlD
Adefovir Dipivoxil—NME2—adipose tissue—breast cancer	0.000991	0.0185	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—lymph node—breast cancer	0.000972	0.0182	CbGeAlD
Adefovir Dipivoxil—NME1—female reproductive system—breast cancer	0.000967	0.0181	CbGeAlD
Adefovir Dipivoxil—NME1—adrenal gland—breast cancer	0.000943	0.0177	CbGeAlD
Adefovir Dipivoxil—AK4—female reproductive system—breast cancer	0.000932	0.0174	CbGeAlD
Adefovir Dipivoxil—NME1—bone marrow—breast cancer	0.000913	0.0171	CbGeAlD
Adefovir Dipivoxil—NME2—female reproductive system—breast cancer	0.000911	0.017	CbGeAlD
Adefovir Dipivoxil—AK4—adrenal gland—breast cancer	0.000909	0.017	CbGeAlD
Adefovir Dipivoxil—NME2—adrenal gland—breast cancer	0.000889	0.0166	CbGeAlD
Adefovir Dipivoxil—NME1—female gonad—breast cancer	0.00088	0.0165	CbGeAlD
Adefovir Dipivoxil—AK4—female gonad—breast cancer	0.000848	0.0159	CbGeAlD
Adefovir Dipivoxil—NME2—female gonad—breast cancer	0.000829	0.0155	CbGeAlD
Adefovir Dipivoxil—NME1—endocrine gland—breast cancer	0.000818	0.0153	CbGeAlD
Adefovir Dipivoxil—AK4—endocrine gland—breast cancer	0.000788	0.0148	CbGeAlD
Adefovir Dipivoxil—NME2—endocrine gland—breast cancer	0.000771	0.0144	CbGeAlD
Adefovir Dipivoxil—SLC22A3—nipple—breast cancer	0.000756	0.0141	CbGeAlD
Adefovir Dipivoxil—AK2—lymph node—breast cancer	0.000737	0.0138	CbGeAlD
Adefovir Dipivoxil—SLC22A3—embryo—breast cancer	0.000624	0.0117	CbGeAlD
Adefovir Dipivoxil—ABCC5—pituitary gland—breast cancer	0.000578	0.0108	CbGeAlD
Adefovir Dipivoxil—ABCC5—adipose tissue—breast cancer	0.000575	0.0108	CbGeAlD
Adefovir Dipivoxil—NME1—lymph node—breast cancer	0.000565	0.0106	CbGeAlD
Adefovir Dipivoxil—AK4—lymph node—breast cancer	0.000545	0.0102	CbGeAlD
Adefovir Dipivoxil—NME2—lymph node—breast cancer	0.000533	0.00997	CbGeAlD
Adefovir Dipivoxil—ABCC5—adrenal gland—breast cancer	0.000516	0.00966	CbGeAlD
Adefovir Dipivoxil—ABCC5—bone marrow—breast cancer	0.000499	0.00934	CbGeAlD
Adefovir Dipivoxil—NME1—Loperamide—Toremifene—breast cancer	0.000486	0.216	CbGdCrCtD
Adefovir Dipivoxil—ABCC5—female gonad—breast cancer	0.000481	0.00901	CbGeAlD
Adefovir Dipivoxil—SLC22A3—endometrium—breast cancer	0.000456	0.00854	CbGeAlD
Adefovir Dipivoxil—SLC22A3—adipose tissue—breast cancer	0.000411	0.0077	CbGeAlD
Adefovir Dipivoxil—ABCC4—uterus—breast cancer	0.000408	0.00763	CbGeAlD
Adefovir Dipivoxil—ABCC4—adipose tissue—breast cancer	0.000399	0.00746	CbGeAlD
Adefovir Dipivoxil—SLC22A3—female reproductive system—breast cancer	0.000378	0.00708	CbGeAlD
Adefovir Dipivoxil—SLC22A3—adrenal gland—breast cancer	0.000369	0.0069	CbGeAlD
Adefovir Dipivoxil—ABCC4—female reproductive system—breast cancer	0.000367	0.00686	CbGeAlD
Adefovir Dipivoxil—ABCC4—adrenal gland—breast cancer	0.000358	0.00669	CbGeAlD
Adefovir Dipivoxil—ABCC4—bone marrow—breast cancer	0.000346	0.00648	CbGeAlD
Adefovir Dipivoxil—SLC22A3—female gonad—breast cancer	0.000344	0.00644	CbGeAlD
Adefovir Dipivoxil—ABCC4—female gonad—breast cancer	0.000334	0.00624	CbGeAlD
Adefovir Dipivoxil—SLC22A3—endocrine gland—breast cancer	0.00032	0.00599	CbGeAlD
Adefovir Dipivoxil—ABCC4—endocrine gland—breast cancer	0.00031	0.00581	CbGeAlD
Adefovir Dipivoxil—ABCC5—lymph node—breast cancer	0.000309	0.00579	CbGeAlD
Adefovir Dipivoxil—NME1—Loperamide—Tamoxifen—breast cancer	0.000305	0.136	CbGdCrCtD
Adefovir Dipivoxil—SLC22A3—lymph node—breast cancer	0.000221	0.00414	CbGeAlD
Adefovir Dipivoxil—ABCC4—lymph node—breast cancer	0.000214	0.00401	CbGeAlD
Adefovir Dipivoxil—Chest pain—Paclitaxel—breast cancer	7.32e-05	0.000597	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Paclitaxel—breast cancer	7.32e-05	0.000597	CcSEcCtD
Adefovir Dipivoxil—Headache—Goserelin—breast cancer	7.3e-05	0.000595	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Docetaxel—breast cancer	7.29e-05	0.000595	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Gemcitabine—breast cancer	7.29e-05	0.000594	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	7.27e-05	0.000593	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Fluorouracil—breast cancer	7.26e-05	0.000592	CcSEcCtD
Adefovir Dipivoxil—Nausea—Tamoxifen—breast cancer	7.25e-05	0.000591	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Gemcitabine—breast cancer	7.24e-05	0.00059	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Epirubicin—breast cancer	7.2e-05	0.000587	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Fluorouracil—breast cancer	7.17e-05	0.000584	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Thiotepa—breast cancer	7.15e-05	0.000583	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Vinorelbine—breast cancer	7.14e-05	0.000582	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Fluorouracil—breast cancer	7.12e-05	0.00058	CcSEcCtD
Adefovir Dipivoxil—Nausea—Melphalan—breast cancer	7.1e-05	0.000579	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Doxorubicin—breast cancer	7.08e-05	0.000577	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Capecitabine—breast cancer	7.06e-05	0.000576	CcSEcCtD
Adefovir Dipivoxil—Back pain—Docetaxel—breast cancer	7.05e-05	0.000575	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Thiotepa—breast cancer	7.05e-05	0.000575	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Mitoxantrone—breast cancer	7.04e-05	0.000574	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Irinotecan—breast cancer	7.04e-05	0.000574	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Doxorubicin—breast cancer	6.98e-05	0.000569	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Capecitabine—breast cancer	6.96e-05	0.000567	CcSEcCtD
Adefovir Dipivoxil—Nausea—Goserelin—breast cancer	6.92e-05	0.000564	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Epirubicin—breast cancer	6.92e-05	0.000564	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Paclitaxel—breast cancer	6.89e-05	0.000561	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Paclitaxel—breast cancer	6.87e-05	0.00056	CcSEcCtD
Adefovir Dipivoxil—Back pain—Capecitabine—breast cancer	6.83e-05	0.000557	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Thiotepa—breast cancer	6.82e-05	0.000556	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Paclitaxel—breast cancer	6.82e-05	0.000556	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Mitoxantrone—breast cancer	6.81e-05	0.000555	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Irinotecan—breast cancer	6.81e-05	0.000555	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Irinotecan—breast cancer	6.81e-05	0.000555	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Mitoxantrone—breast cancer	6.81e-05	0.000555	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Docetaxel—breast cancer	6.74e-05	0.00055	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Paclitaxel—breast cancer	6.69e-05	0.000546	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Doxorubicin—breast cancer	6.66e-05	0.000543	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Vinorelbine—breast cancer	6.64e-05	0.000541	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Gemcitabine—breast cancer	6.63e-05	0.000541	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Methotrexate—breast cancer	6.61e-05	0.000539	CcSEcCtD
Adefovir Dipivoxil—Rash—Vinorelbine—breast cancer	6.58e-05	0.000537	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Vinorelbine—breast cancer	6.58e-05	0.000536	CcSEcCtD
Adefovir Dipivoxil—Headache—Vinorelbine—breast cancer	6.54e-05	0.000533	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Capecitabine—breast cancer	6.53e-05	0.000532	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Fluorouracil—breast cancer	6.52e-05	0.000531	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Methotrexate—breast cancer	6.41e-05	0.000523	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Doxorubicin—breast cancer	6.4e-05	0.000522	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Paclitaxel—breast cancer	6.4e-05	0.000522	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Epirubicin—breast cancer	6.39e-05	0.000521	CcSEcCtD
Adefovir Dipivoxil—Cough—Docetaxel—breast cancer	6.36e-05	0.000519	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Methotrexate—breast cancer	6.36e-05	0.000519	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Thiotepa—breast cancer	6.34e-05	0.000517	CcSEcCtD
Adefovir Dipivoxil—Rash—Thiotepa—breast cancer	6.29e-05	0.000512	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Thiotepa—breast cancer	6.28e-05	0.000512	CcSEcCtD
Adefovir Dipivoxil—Headache—Thiotepa—breast cancer	6.25e-05	0.000509	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Docetaxel—breast cancer	6.21e-05	0.000506	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Docetaxel—breast cancer	6.21e-05	0.000506	CcSEcCtD
Adefovir Dipivoxil—Nausea—Vinorelbine—breast cancer	6.2e-05	0.000506	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Epirubicin—breast cancer	6.19e-05	0.000504	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Paclitaxel—breast cancer	6.18e-05	0.000504	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Mitoxantrone—breast cancer	6.18e-05	0.000504	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Irinotecan—breast cancer	6.18e-05	0.000504	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.17e-05	0.000503	CcSEcCtD
Adefovir Dipivoxil—Cough—Capecitabine—breast cancer	6.16e-05	0.000502	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Epirubicin—breast cancer	6.13e-05	0.0005	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Paclitaxel—breast cancer	6.1e-05	0.000498	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Paclitaxel—breast cancer	6.06e-05	0.000494	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Methotrexate—breast cancer	6.04e-05	0.000492	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Gemcitabine—breast cancer	6.02e-05	0.000491	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Capecitabine—breast cancer	6.01e-05	0.00049	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Capecitabine—breast cancer	6.01e-05	0.00049	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Epirubicin—breast cancer	6e-05	0.000489	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Methotrexate—breast cancer	5.99e-05	0.000489	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	5.97e-05	0.000487	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Methotrexate—breast cancer	5.96e-05	0.000486	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Epirubicin—breast cancer	5.95e-05	0.000485	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Gemcitabine—breast cancer	5.93e-05	0.000484	CcSEcCtD
Adefovir Dipivoxil—Nausea—Thiotepa—breast cancer	5.92e-05	0.000483	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Methotrexate—breast cancer	5.92e-05	0.000483	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Doxorubicin—breast cancer	5.91e-05	0.000482	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Epirubicin—breast cancer	5.9e-05	0.000481	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Irinotecan—breast cancer	5.89e-05	0.00048	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Mitoxantrone—breast cancer	5.89e-05	0.00048	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Docetaxel—breast cancer	5.84e-05	0.000476	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Fluorouracil—breast cancer	5.83e-05	0.000476	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Docetaxel—breast cancer	5.83e-05	0.000475	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Docetaxel—breast cancer	5.78e-05	0.000471	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Paclitaxel—breast cancer	5.74e-05	0.000468	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Gemcitabine—breast cancer	5.74e-05	0.000468	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Doxorubicin—breast cancer	5.72e-05	0.000467	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Doxorubicin—breast cancer	5.68e-05	0.000463	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Docetaxel—breast cancer	5.67e-05	0.000463	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Capecitabine—breast cancer	5.65e-05	0.000461	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Epirubicin—breast cancer	5.65e-05	0.000461	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Fluorouracil—breast cancer	5.64e-05	0.00046	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Capecitabine—breast cancer	5.64e-05	0.00046	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Epirubicin—breast cancer	5.61e-05	0.000457	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Capecitabine—breast cancer	5.6e-05	0.000456	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Epirubicin—breast cancer	5.58e-05	0.000455	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Doxorubicin—breast cancer	5.55e-05	0.000453	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Epirubicin—breast cancer	5.55e-05	0.000453	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Paclitaxel—breast cancer	5.55e-05	0.000453	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Paclitaxel—breast cancer	5.55e-05	0.000453	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Epirubicin—breast cancer	5.54e-05	0.000452	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Doxorubicin—breast cancer	5.51e-05	0.000449	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Capecitabine—breast cancer	5.49e-05	0.000448	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Irinotecan—breast cancer	5.47e-05	0.000446	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Mitoxantrone—breast cancer	5.47e-05	0.000446	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Doxorubicin—breast cancer	5.46e-05	0.000445	CcSEcCtD
Adefovir Dipivoxil—Rash—Mitoxantrone—breast cancer	5.43e-05	0.000443	CcSEcCtD
Adefovir Dipivoxil—Rash—Irinotecan—breast cancer	5.43e-05	0.000443	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Mitoxantrone—breast cancer	5.42e-05	0.000442	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Irinotecan—breast cancer	5.42e-05	0.000442	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Docetaxel—breast cancer	5.42e-05	0.000442	CcSEcCtD
Adefovir Dipivoxil—Headache—Mitoxantrone—breast cancer	5.39e-05	0.00044	CcSEcCtD
Adefovir Dipivoxil—Headache—Irinotecan—breast cancer	5.39e-05	0.00044	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Gemcitabine—breast cancer	5.33e-05	0.000435	CcSEcCtD
Adefovir Dipivoxil—Rash—Gemcitabine—breast cancer	5.29e-05	0.000431	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Gemcitabine—breast cancer	5.28e-05	0.000431	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Methotrexate—breast cancer	5.26e-05	0.000429	CcSEcCtD
Adefovir Dipivoxil—Headache—Gemcitabine—breast cancer	5.25e-05	0.000428	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Capecitabine—breast cancer	5.25e-05	0.000428	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Fluorouracil—breast cancer	5.24e-05	0.000427	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Docetaxel—breast cancer	5.24e-05	0.000427	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Doxorubicin—breast cancer	5.23e-05	0.000426	CcSEcCtD
Adefovir Dipivoxil—Rash—Fluorouracil—breast cancer	5.2e-05	0.000424	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Fluorouracil—breast cancer	5.19e-05	0.000423	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Doxorubicin—breast cancer	5.19e-05	0.000423	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Docetaxel—breast cancer	5.17e-05	0.000422	CcSEcCtD
Adefovir Dipivoxil—Headache—Fluorouracil—breast cancer	5.17e-05	0.000421	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Doxorubicin—breast cancer	5.16e-05	0.000421	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Docetaxel—breast cancer	5.14e-05	0.000419	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Doxorubicin—breast cancer	5.14e-05	0.000419	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Doxorubicin—breast cancer	5.12e-05	0.000418	CcSEcCtD
Adefovir Dipivoxil—Nausea—Irinotecan—breast cancer	5.11e-05	0.000417	CcSEcCtD
Adefovir Dipivoxil—Nausea—Mitoxantrone—breast cancer	5.11e-05	0.000417	CcSEcCtD
Adefovir Dipivoxil—Back pain—Methotrexate—breast cancer	5.08e-05	0.000414	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Capecitabine—breast cancer	5.07e-05	0.000414	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Paclitaxel—breast cancer	5.04e-05	0.000411	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Capecitabine—breast cancer	5.01e-05	0.000408	CcSEcCtD
Adefovir Dipivoxil—Nausea—Gemcitabine—breast cancer	4.98e-05	0.000406	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Capecitabine—breast cancer	4.97e-05	0.000406	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Paclitaxel—breast cancer	4.97e-05	0.000405	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Epirubicin—breast cancer	4.92e-05	0.000401	CcSEcCtD
Adefovir Dipivoxil—Nausea—Fluorouracil—breast cancer	4.9e-05	0.000399	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Docetaxel—breast cancer	4.87e-05	0.000397	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Methotrexate—breast cancer	4.86e-05	0.000396	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Epirubicin—breast cancer	4.85e-05	0.000395	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Paclitaxel—breast cancer	4.8e-05	0.000392	CcSEcCtD
Adefovir Dipivoxil—Back pain—Epirubicin—breast cancer	4.76e-05	0.000388	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Capecitabine—breast cancer	4.71e-05	0.000384	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Docetaxel—breast cancer	4.7e-05	0.000384	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Docetaxel—breast cancer	4.7e-05	0.000384	CcSEcCtD
Adefovir Dipivoxil—Cough—Methotrexate—breast cancer	4.59e-05	0.000374	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Capecitabine—breast cancer	4.55e-05	0.000371	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Capecitabine—breast cancer	4.55e-05	0.000371	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Doxorubicin—breast cancer	4.55e-05	0.000371	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Epirubicin—breast cancer	4.55e-05	0.000371	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Doxorubicin—breast cancer	4.48e-05	0.000366	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Methotrexate—breast cancer	4.47e-05	0.000365	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Methotrexate—breast cancer	4.47e-05	0.000365	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Paclitaxel—breast cancer	4.46e-05	0.000364	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.44e-05	0.000362	CcSEcCtD
Adefovir Dipivoxil—Rash—Paclitaxel—breast cancer	4.43e-05	0.000361	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Paclitaxel—breast cancer	4.42e-05	0.000361	CcSEcCtD
Adefovir Dipivoxil—Back pain—Doxorubicin—breast cancer	4.4e-05	0.000359	CcSEcCtD
Adefovir Dipivoxil—Headache—Paclitaxel—breast cancer	4.4e-05	0.000359	CcSEcCtD
Adefovir Dipivoxil—Cough—Epirubicin—breast cancer	4.29e-05	0.00035	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Docetaxel—breast cancer	4.27e-05	0.000348	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Docetaxel—breast cancer	4.21e-05	0.000343	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Methotrexate—breast cancer	4.21e-05	0.000343	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Doxorubicin—breast cancer	4.21e-05	0.000343	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Methotrexate—breast cancer	4.2e-05	0.000342	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Epirubicin—breast cancer	4.19e-05	0.000341	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Epirubicin—breast cancer	4.19e-05	0.000341	CcSEcCtD
Adefovir Dipivoxil—Nausea—Paclitaxel—breast cancer	4.17e-05	0.00034	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Methotrexate—breast cancer	4.17e-05	0.00034	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.16e-05	0.000339	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Capecitabine—breast cancer	4.13e-05	0.000337	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Methotrexate—breast cancer	4.09e-05	0.000333	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Capecitabine—breast cancer	4.08e-05	0.000332	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Docetaxel—breast cancer	4.07e-05	0.000332	CcSEcCtD
Adefovir Dipivoxil—Cough—Doxorubicin—breast cancer	3.97e-05	0.000324	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Capecitabine—breast cancer	3.94e-05	0.000321	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Epirubicin—breast cancer	3.94e-05	0.000321	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Epirubicin—breast cancer	3.93e-05	0.00032	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Methotrexate—breast cancer	3.91e-05	0.000319	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Epirubicin—breast cancer	3.9e-05	0.000318	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Doxorubicin—breast cancer	3.87e-05	0.000316	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Doxorubicin—breast cancer	3.87e-05	0.000316	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.85e-05	0.000314	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Epirubicin—breast cancer	3.83e-05	0.000312	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Docetaxel—breast cancer	3.78e-05	0.000309	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Methotrexate—breast cancer	3.78e-05	0.000308	CcSEcCtD
Adefovir Dipivoxil—Rash—Docetaxel—breast cancer	3.75e-05	0.000306	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Docetaxel—breast cancer	3.75e-05	0.000306	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Methotrexate—breast cancer	3.73e-05	0.000304	CcSEcCtD
Adefovir Dipivoxil—Headache—Docetaxel—breast cancer	3.73e-05	0.000304	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Methotrexate—breast cancer	3.7e-05	0.000302	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Capecitabine—breast cancer	3.66e-05	0.000299	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Epirubicin—breast cancer	3.66e-05	0.000298	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Doxorubicin—breast cancer	3.64e-05	0.000297	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Doxorubicin—breast cancer	3.64e-05	0.000296	CcSEcCtD
Adefovir Dipivoxil—Rash—Capecitabine—breast cancer	3.63e-05	0.000296	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Capecitabine—breast cancer	3.63e-05	0.000296	CcSEcCtD
Adefovir Dipivoxil—Headache—Capecitabine—breast cancer	3.61e-05	0.000294	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Doxorubicin—breast cancer	3.61e-05	0.000294	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Doxorubicin—breast cancer	3.54e-05	0.000289	CcSEcCtD
Adefovir Dipivoxil—Nausea—Docetaxel—breast cancer	3.53e-05	0.000288	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Epirubicin—breast cancer	3.53e-05	0.000288	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Methotrexate—breast cancer	3.51e-05	0.000286	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Epirubicin—breast cancer	3.49e-05	0.000284	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Epirubicin—breast cancer	3.47e-05	0.000283	CcSEcCtD
Adefovir Dipivoxil—Nausea—Capecitabine—breast cancer	3.42e-05	0.000279	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Methotrexate—breast cancer	3.39e-05	0.000276	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Methotrexate—breast cancer	3.39e-05	0.000276	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.38e-05	0.000276	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Epirubicin—breast cancer	3.28e-05	0.000268	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Doxorubicin—breast cancer	3.27e-05	0.000267	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Doxorubicin—breast cancer	3.23e-05	0.000263	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Doxorubicin—breast cancer	3.21e-05	0.000261	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Epirubicin—breast cancer	3.17e-05	0.000259	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Epirubicin—breast cancer	3.17e-05	0.000259	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Methotrexate—breast cancer	3.08e-05	0.000251	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Doxorubicin—breast cancer	3.04e-05	0.000248	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Methotrexate—breast cancer	3.03e-05	0.000247	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Doxorubicin—breast cancer	2.94e-05	0.000239	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Doxorubicin—breast cancer	2.94e-05	0.000239	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Methotrexate—breast cancer	2.93e-05	0.000239	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Epirubicin—breast cancer	2.88e-05	0.000235	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Epirubicin—breast cancer	2.84e-05	0.000232	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Epirubicin—breast cancer	2.75e-05	0.000224	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Methotrexate—breast cancer	2.73e-05	0.000222	CcSEcCtD
Adefovir Dipivoxil—Rash—Methotrexate—breast cancer	2.7e-05	0.000221	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Methotrexate—breast cancer	2.7e-05	0.00022	CcSEcCtD
Adefovir Dipivoxil—Headache—Methotrexate—breast cancer	2.69e-05	0.000219	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Doxorubicin—breast cancer	2.66e-05	0.000217	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Doxorubicin—breast cancer	2.63e-05	0.000214	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Epirubicin—breast cancer	2.55e-05	0.000208	CcSEcCtD
Adefovir Dipivoxil—Nausea—Methotrexate—breast cancer	2.55e-05	0.000208	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Doxorubicin—breast cancer	2.54e-05	0.000207	CcSEcCtD
Adefovir Dipivoxil—Rash—Epirubicin—breast cancer	2.53e-05	0.000206	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Epirubicin—breast cancer	2.53e-05	0.000206	CcSEcCtD
Adefovir Dipivoxil—Headache—Epirubicin—breast cancer	2.51e-05	0.000205	CcSEcCtD
Adefovir Dipivoxil—Nausea—Epirubicin—breast cancer	2.38e-05	0.000194	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Doxorubicin—breast cancer	2.36e-05	0.000193	CcSEcCtD
Adefovir Dipivoxil—Rash—Doxorubicin—breast cancer	2.34e-05	0.000191	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Doxorubicin—breast cancer	2.34e-05	0.000191	CcSEcCtD
Adefovir Dipivoxil—Headache—Doxorubicin—breast cancer	2.33e-05	0.00019	CcSEcCtD
Adefovir Dipivoxil—Nausea—Doxorubicin—breast cancer	2.21e-05	0.00018	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—PTEN—breast cancer	1.34e-05	0.000148	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IL2—breast cancer	1.34e-05	0.000148	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—PLG—breast cancer	1.33e-05	0.000147	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PLA2G4A—breast cancer	1.32e-05	0.000146	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HGF—breast cancer	1.32e-05	0.000146	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GPX2—breast cancer	1.31e-05	0.000146	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTA2—breast cancer	1.31e-05	0.000146	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NCOA3—breast cancer	1.31e-05	0.000145	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CSF2—breast cancer	1.3e-05	0.000145	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC2A2—breast cancer	1.3e-05	0.000144	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GPX4—breast cancer	1.3e-05	0.000144	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SULT1A1—breast cancer	1.3e-05	0.000144	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.3e-05	0.000144	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGF3—breast cancer	1.28e-05	0.000142	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—HMOX1—breast cancer	1.28e-05	0.000142	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ABCG2—breast cancer	1.27e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MTR—breast cancer	1.27e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CPT1A—breast cancer	1.27e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—IDH1—breast cancer	1.27e-05	0.00014	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTA1—breast cancer	1.27e-05	0.00014	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FASN—breast cancer	1.26e-05	0.00014	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—JAG1—breast cancer	1.26e-05	0.00014	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—MTHFR—breast cancer	1.26e-05	0.00014	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	1.26e-05	0.00014	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PARP1—breast cancer	1.26e-05	0.00014	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NAT2—breast cancer	1.25e-05	0.000139	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HPGDS—breast cancer	1.25e-05	0.000138	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CALCA—breast cancer	1.24e-05	0.000138	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HBA1—breast cancer	1.24e-05	0.000138	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CD—breast cancer	1.23e-05	0.000136	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—RPS6—breast cancer	1.23e-05	0.000136	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ABCB1—breast cancer	1.23e-05	0.000136	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—HMOX1—breast cancer	1.23e-05	0.000136	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGF4—breast cancer	1.22e-05	0.000135	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CXCR4—breast cancer	1.22e-05	0.000135	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ALB—breast cancer	1.21e-05	0.000135	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ACHE—breast cancer	1.21e-05	0.000134	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTT1—breast cancer	1.21e-05	0.000134	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SLC2A1—breast cancer	1.2e-05	0.000133	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	1.19e-05	0.000131	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ABCB1—breast cancer	1.18e-05	0.00013	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TCF7L2—breast cancer	1.17e-05	0.00013	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SRC—breast cancer	1.17e-05	0.000129	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CAV1—breast cancer	1.16e-05	0.000129	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—NOS3—breast cancer	1.16e-05	0.000129	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	1.16e-05	0.000128	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP17A1—breast cancer	1.15e-05	0.000127	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—breast cancer	1.14e-05	0.000126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ENO1—breast cancer	1.13e-05	0.000126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS1—breast cancer	1.13e-05	0.000126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HSP90AA1—breast cancer	1.13e-05	0.000125	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MMP1—breast cancer	1.12e-05	0.000124	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP2D6—breast cancer	1.11e-05	0.000123	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PLAU—breast cancer	1.1e-05	0.000122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CDK2—breast cancer	1.1e-05	0.000122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PRL—breast cancer	1.1e-05	0.000122	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MED12—breast cancer	1.1e-05	0.000122	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—DPYD—breast cancer	1.1e-05	0.000122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NCOA2—breast cancer	1.09e-05	0.000121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ADAM10—breast cancer	1.08e-05	0.00012	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALDOA—breast cancer	1.08e-05	0.00012	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CAV1—breast cancer	1.07e-05	0.000119	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—MAPK3—breast cancer	1.07e-05	0.000119	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CB—breast cancer	1.07e-05	0.000119	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	1.07e-05	0.000118	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTGS2—breast cancer	1.06e-05	0.000118	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ALB—breast cancer	1.06e-05	0.000118	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CG—breast cancer	1.06e-05	0.000118	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—FASN—breast cancer	1.06e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—BCHE—breast cancer	1.05e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGF10—breast cancer	1.05e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NCOA3—breast cancer	1.05e-05	0.000116	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—breast cancer	1.04e-05	0.000116	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC2A2—breast cancer	1.04e-05	0.000116	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC5A5—breast cancer	1.04e-05	0.000116	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	1.02e-05	0.000113	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—FN1—breast cancer	1.02e-05	0.000113	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CPT1A—breast cancer	1.02e-05	0.000113	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MTR—breast cancer	1.02e-05	0.000113	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ABCG2—breast cancer	1.02e-05	0.000113	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PDGFA—breast cancer	1.02e-05	0.000113	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NOS2—breast cancer	1.01e-05	0.000112	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC2A1—breast cancer	1.01e-05	0.000112	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NQO1—breast cancer	1.01e-05	0.000112	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFBR2—breast cancer	1e-05	0.000111	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HPGDS—breast cancer	1e-05	0.000111	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HBA1—breast cancer	9.95e-06	0.00011	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ITPR1—breast cancer	9.86e-06	0.000109	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP3A4—breast cancer	9.81e-06	0.000109	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERBB4—breast cancer	9.8e-06	0.000109	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT5A—breast cancer	9.8e-06	0.000109	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CG—breast cancer	9.79e-06	0.000109	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ACHE—breast cancer	9.71e-06	0.000108	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTT1—breast cancer	9.71e-06	0.000108	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—EGF—breast cancer	9.68e-06	0.000107	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP1B1—breast cancer	9.65e-06	0.000107	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—RAF1—breast cancer	9.6e-06	0.000106	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SMAD4—breast cancer	9.49e-06	0.000105	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HSP90AA1—breast cancer	9.46e-06	0.000105	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CA—breast cancer	9.43e-06	0.000105	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CD—breast cancer	9.32e-06	0.000103	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTEN—breast cancer	9.27e-06	0.000103	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HES1—breast cancer	9.26e-06	0.000103	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NCOR1—breast cancer	9.21e-06	0.000102	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NCOA1—breast cancer	9.2e-06	0.000102	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALB—breast cancer	9.2e-06	0.000102	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP17A1—breast cancer	9.19e-06	0.000102	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGF1—breast cancer	9.11e-06	0.000101	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ENO1—breast cancer	9.1e-06	0.000101	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS1—breast cancer	9.1e-06	0.000101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP19A1—breast cancer	9.07e-06	0.000101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—STK11—breast cancer	9.07e-06	0.000101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NRG1—breast cancer	9.04e-06	0.0001	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—H2AFX—breast cancer	8.98e-06	9.95e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IGF1—breast cancer	8.96e-06	9.94e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT2—breast cancer	8.96e-06	9.93e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP2D6—breast cancer	8.92e-06	9.9e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	8.87e-06	9.84e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—NOS3—breast cancer	8.8e-06	9.76e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NCOA2—breast cancer	8.76e-06	9.71e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERCC2—breast cancer	8.66e-06	9.6e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CD—breast cancer	8.61e-06	9.54e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SERPINE1—breast cancer	8.51e-06	9.44e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ALB—breast cancer	8.51e-06	9.44e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ALB—breast cancer	8.5e-06	9.42e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—FASN—breast cancer	8.5e-06	9.42e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERBB3—breast cancer	8.47e-06	9.39e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—BCHE—breast cancer	8.46e-06	9.38e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGFR2—breast cancer	8.46e-06	9.38e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—COMT—breast cancer	8.43e-06	9.35e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTP1—breast cancer	8.39e-06	9.31e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC5A5—breast cancer	8.36e-06	9.27e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HMOX1—breast cancer	8.28e-06	9.18e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ITPR1—breast cancer	8.26e-06	9.16e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTHFR—breast cancer	8.14e-06	9.03e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NOS3—breast cancer	8.13e-06	9.01e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CB—breast cancer	8.13e-06	9.01e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TERT—breast cancer	8.12e-06	9e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC2A1—breast cancer	8.07e-06	8.95e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NQO1—breast cancer	8.07e-06	8.95e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTGS2—breast cancer	8.05e-06	8.93e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ABCB1—breast cancer	7.95e-06	8.81e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGFR1—breast cancer	7.88e-06	8.74e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP3A4—breast cancer	7.87e-06	8.73e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TYMS—breast cancer	7.8e-06	8.65e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HIF1A—breast cancer	7.76e-06	8.61e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP1B1—breast cancer	7.74e-06	8.58e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PLA2G4A—breast cancer	7.71e-06	8.55e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTM1—breast cancer	7.71e-06	8.55e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NCOR1—breast cancer	7.71e-06	8.55e-05	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKT1—breast cancer	7.7e-06	8.54e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—RAF1—breast cancer	7.7e-06	8.53e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—RAF1—breast cancer	7.68e-06	8.52e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	7.67e-06	8.51e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HSP90AA1—breast cancer	7.59e-06	8.41e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CAV1—breast cancer	7.51e-06	8.32e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CB—breast cancer	7.5e-06	8.32e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GPX1—breast cancer	7.39e-06	8.19e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NCOA1—breast cancer	7.38e-06	8.19e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ALB—breast cancer	7.36e-06	8.16e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP1A1—breast cancer	7.31e-06	8.11e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—STK11—breast cancer	7.28e-06	8.07e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP19A1—breast cancer	7.28e-06	8.07e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ERCC2—breast cancer	7.25e-06	8.04e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—AKT1—breast cancer	7.25e-06	8.04e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOS2—breast cancer	7.06e-06	7.83e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTEN—breast cancer	7.02e-06	7.79e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOTCH1—breast cancer	6.99e-06	7.75e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	6.94e-06	7.69e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL2—breast cancer	6.89e-06	7.64e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KIT—breast cancer	6.84e-06	7.58e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—APC—breast cancer	6.84e-06	7.58e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MTHFR—breast cancer	6.82e-06	7.56e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—COMT—breast cancer	6.76e-06	7.5e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGF—breast cancer	6.76e-06	7.5e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTP1—breast cancer	6.73e-06	7.46e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—RAF1—breast cancer	6.65e-06	7.38e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HMOX1—breast cancer	6.64e-06	7.36e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ITPR1—breast cancer	6.62e-06	7.34e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CA—breast cancer	6.54e-06	7.25e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—BRAF—breast cancer	6.43e-06	7.13e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	6.4e-06	7.1e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ABCB1—breast cancer	6.37e-06	7.07e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CAV1—breast cancer	6.29e-06	6.97e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TYMS—breast cancer	6.26e-06	6.94e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT2—breast cancer	6.26e-06	6.94e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PLA2G4A—breast cancer	6.19e-06	6.86e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTM1—breast cancer	6.19e-06	6.86e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NCOR1—breast cancer	6.19e-06	6.86e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SRC—breast cancer	6.01e-06	6.67e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CD—breast cancer	6.01e-06	6.67e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SERPINE1—breast cancer	5.95e-06	6.59e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GPX1—breast cancer	5.92e-06	6.57e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP1A1—breast cancer	5.86e-06	6.5e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VEGFA—breast cancer	5.86e-06	6.49e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ERCC2—breast cancer	5.82e-06	6.45e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	5.79e-06	6.42e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CG—breast cancer	5.73e-06	6.35e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOS3—breast cancer	5.68e-06	6.29e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MAPK3—breast cancer	5.54e-06	6.14e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MTHFR—breast cancer	5.47e-06	6.06e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MDM2—breast cancer	5.39e-06	5.97e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TGFB1—breast cancer	5.37e-06	5.96e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—RAF1—breast cancer	5.37e-06	5.95e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKT1—breast cancer	5.34e-06	5.92e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERBB2—breast cancer	5.31e-06	5.89e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTOR—breast cancer	5.24e-06	5.81e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CB—breast cancer	5.24e-06	5.81e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CD4—breast cancer	5.23e-06	5.8e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTGS2—breast cancer	5.19e-06	5.76e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CAV1—breast cancer	5.04e-06	5.59e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CD—breast cancer	5.03e-06	5.58e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—KRAS—breast cancer	4.98e-06	5.52e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALB—breast cancer	4.97e-06	5.51e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CA—breast cancer	4.95e-06	5.49e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN1B—breast cancer	4.92e-06	5.45e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NOS3—breast cancer	4.75e-06	5.27e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CTNNB1—breast cancer	4.65e-06	5.15e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CG—breast cancer	4.59e-06	5.09e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CA—breast cancer	4.57e-06	5.07e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN1A—breast cancer	4.54e-06	5.03e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTEN—breast cancer	4.53e-06	5.02e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—breast cancer	4.42e-06	4.91e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CB—breast cancer	4.39e-06	4.87e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS2—breast cancer	4.35e-06	4.82e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HRAS—breast cancer	4.23e-06	4.69e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SRC—breast cancer	4.2e-06	4.66e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT3—breast cancer	4.05e-06	4.49e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKT1—breast cancer	4.05e-06	4.49e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CD—breast cancer	4.04e-06	4.48e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALB—breast cancer	3.99e-06	4.42e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAPK3—breast cancer	3.87e-06	4.29e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NOS3—breast cancer	3.81e-06	4.23e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTEN—breast cancer	3.79e-06	4.2e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MYC—breast cancer	3.76e-06	4.17e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFB1—breast cancer	3.75e-06	4.16e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT1—breast cancer	3.74e-06	4.14e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGFR—breast cancer	3.68e-06	4.08e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CB—breast cancer	3.52e-06	3.9e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS2—breast cancer	3.49e-06	3.87e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KRAS—breast cancer	3.48e-06	3.86e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CA—breast cancer	3.19e-06	3.54e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTEN—breast cancer	3.04e-06	3.37e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HRAS—breast cancer	2.96e-06	3.28e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6—breast cancer	2.83e-06	3.14e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CA—breast cancer	2.68e-06	2.97e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT1—breast cancer	2.61e-06	2.89e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKT1—breast cancer	2.19e-06	2.42e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CA—breast cancer	2.15e-06	2.38e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKT1—breast cancer	1.75e-06	1.94e-05	CbGpPWpGaD
